Dacarbazine (DTIC)-based chemotherapy or chemoimmunotherapy of patients with disseminated malignant melanoma. [electronic resource]
Producer: 19941108Description: 681-3 p. digitalISSN:- 0007-0920
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bleomycin -- administration & dosage
- Combined Modality Therapy
- Dacarbazine -- administration & dosage
- Dactinomycin -- administration & dosage
- Female
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Humans
- Immunotherapy
- Interferon-alpha -- administration & dosage
- Male
- Melanoma -- drug therapy
- Middle Aged
- Treatment Outcome
- Vinblastine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.